Abstract. Materials and Methods
|
|
- Jocelin Grant
- 6 years ago
- Views:
Transcription
1 Hematopathology / ANAYSIS OF BC-2 IN YMPHOMA AND HYPERPASIA Follicular ymphoma Can Be Distinguished From Benign Follicular Hyperplasia by Flow Cytometry Using Simultaneous Staining of Cytoplasmic bcl-2 and Cell Surface Dennis B. Cornfield, MD, Debra M. Mitchell, MD, Nidal M. Almasri, MD, John B. Anderson, MT, Kim P. Ahrens, BS, Elaine O. Dooley, MT, and Raul C. Braylan, MD Key Words: Flow cytometry; bcl-2; Follicular lymphoma; Follicular hyperplasia Abstract The distinction between benign follicular hyperplasia (FH) and follicular lymphoma (F) is sometimes problematic. We wanted to determine whether the expression of bcl-2 of FH was quantitatively different from that of F, using surface expression as a discriminator of the various lymphoid compartments. ymph node cell suspensions from 12 cases of FH and 17 cases of F were analyzed by flow cytometry using a combined surface and intracellular bcl-2 staining. T cells in FH demonstrated the same bcl-2 expression as the + mantle cells, but the bright + germinal center cells showed near absence of bcl-2 expression. In contrast, the neoplastic cells of F showed greater bcl- 2 expression than the T cells of the same tumors and all cell populations of FH. This difference was particularly significant between the neoplastic B cells of F and the germinal center cells of FH. The combined analysis of and bcl-2 should be useful for the differential diagnosis between FH and F and particularly applicable to limited samples or when B-cell clonality is in question. Whether the quantitation of bcl-2 expression can be of further discriminatory value in malignant lymphomas remains to be determined. The distinction between benign follicular hyperplasia (FH) and follicular lymphoma (F) can sometimes be challenging for surgical pathologists. The bcl-2 oncoprotein, a 26-kd protein that prolongs cell survival by inhibiting apoptosis, 1 has been a particularly useful target for distinguishing FH from F by immunohistochemical means. 2,3 The overexpression of bcl-2 in most cases of F results in its intense staining in the nodules of F, in contrast to the opposite pattern in FH, in which bcl-2 is localized most prominently in the small, nondividing lymphocytes of the mantle zone and, to a lesser extent, the B and T lymphocytes of the interfollicular areas. 4-6 It has been shown that monoclonal antibody to is a useful marker for separating mantle B-cells from germinal center B cells. 7 We found that, by using a relatively simple flow cytometric technique that uses dual staining with monoclonal antibodies to bcl-2 and, F displays a pattern of bcl-2 expression that is distinct from that of FH. Materials and Methods Selection of Samples All samples were submitted to the flow cytometry laboratory of Shands Hospital, University of Florida, Gainesville, for diagnostic purposes. FH samples consisted of lymph nodes displaying benign hyperplastic changes. F samples comprised lymph nodes (14), a small intestinal mass (1), a pharyngeal mass (1), and a parotid mass (1) and were selected based on histologic and flow cytometric findings that included the following: (1) typical morphologic features of F, including a nodular architecture on formalin-fixed H&E-stained tissue; (2) flow cytometric 258 Am J Clin Pathol 2;114: American Society of Clinical Pathologists
2 Hematopathology / ORIGINA ARTICE evidence of clonality as demonstrated by a monotypic population of B lymphocytes expressing kappa or lambda immunoglobulin light chain (15 cases). In 2 cases of F, no immunoglobulin light chain expression was demonstrated on B cells. Of the 17 cases of F, 16 expressed CD1, in keeping with previous findings. 8 Cell Suspension Preparation and Staining Single-cell suspensions were prepared by gentle mechanical tissue mincing. Flow cytometric analysis was performed using a panel of monoclonal antibodies routinely applied in our laboratory for the diagnosis and characterization of lymphoproliferative disorders. Approximately 1 6 cells were exposed to an appropriate dilution of fluorescein isothiocyanate or phycoerythrin-conjugated monoclonal antibody in 96-well microtiter plates (Pro-Bind U-Bottom, Becton Dickinson abware, Franklin akes, NJ). The plates were placed on ice in the dark for 15 minutes, and the cells in the wells were washed twice with phosphate-buffered saline (PBS) and resuspended in 1 µ of a 1:1 dilution of propidium iodide in 1.12% sodium citrate buffer before analysis. In addition, a combined surface and intracellular bcl-2 staining was performed. Approximately 1 6 cells were first exposed to 1 µ of phycoerythrin-conjugated anti- (eu16, Becton Dickinson Immunocytometry Systems, San Jose, CA) on ice for 15 minutes in the dark. Cells were washed twice with PBS and then exposed to the reagents in the Fix and Perm Cell Permeabilization Kit (Caltag, Burlingame, CA), according to the manufacturer s instructions. Cells subsequently were incubated with 1 µ of fluorescein isothiocyanate conjugated anti bcl-2 or the appropriate immunoglobulin control (Pharmingen, San Diego, CA) at room temperature for 15 minutes. After washing with PBS, the cells were resuspended in 5 µ of PBS. A FACScan or a FACSCalibur (Becton Dickinson Immunocytometry Systems) was used for cell analysis, and data analysis was performed by using ysis or CellQuest software (Becton Dickinson Immunocytometry Systems). The fluorescence intensity of the and bcl-2 expressions was determined visually on bivariate plots; bcl-2 expression was quantitated using the mean fluorescence intensity (MFI), calculated as the ratio of mean channel number of bcl-2 expression to that of the isotype-matched control for the -defined population of interest. MFI is expressed as mean ± SD. Immunohistochemical Staining Immunohistochemical staining was performed on formalin-fixed tissue using an anti bcl-2 antibody and an enzyme detection kit (DAKO, Carpinteria, CA) according to the manufacturer s instructions. Molecular Analysis Analysis of bcl-2 gene rearrangement was performed according to the method of iu et al 9 with minor modifications. In short, DNA was extracted from tissue or cell suspensions fixed in a 5% ethanol-rpmi mixture using a nonorganic method. 1 DNA from paraffin-embedded tissues was extracted with xylene through graded alcohols. Primers for the bcl-2 major breakpoint region, minor cluster region, and immunoglobulin heavy chain joining region (JH); consensus segments; and internal probes for the major breakpoint region and minor cluster region were used as described by iu et al. 9 A 2-ng aliquot of genomic DNA was amplified in a Perkin Elmer Cetus 96 thermocycler with 1.25 U of Taq polymerase (Perkin Elmer, Norwalk, CT) in a 5-µ reaction volume containing tris(hydroxymethyl)- aminomethane-hydrochloride buffer, ph 8.3 (Perkin Elmer) and final concentrations of 1. mmol/ of magnesium chloride, 2 µmol/ of dntp ([deoxynucleoside triphosphate] Amersham Pharmacia Biotech, Piscataway, NJ), and.5 µmol/ of each primer. Amplification products were electrophoresed through a 1.75% agarose gel (Ultrapure, Gibco- BR, Gaithersburg, MD) and transferred by semidry electroblotting onto nylon membranes. They then were probed with 3 tailed digoxigenin-labeled oligonucleotides, and amplified bands were detected by chemiluminescence (protocol of Boehringer-Mannheim, Indianapolis, IN). Results All cases in this series demonstrated bcl-2 expression in the lymphoma cells by immunohistochemical staining. By flow cytometry, the analysis of in most FH samples revealed distinct populations of bright +, dim +, and cells Figure 1A. These subpopulations represent mostly germinal center, mantle, and T cells, respectively. 7 In contrast, the presence of neoplastic cells uniformly expressing in F produced an obliteration of the 2 distinct B-cell populations noted in FH, resulting in a single + population Figure 1B. The bcl-2 expression in the B lymphocytes of FH (Figure 1A) was also different from that seen in the cases of F (Figure 1B). As shown in Figure 2, in FH, the intensity of bcl-2 expression in T cells (MFI = 4.7 ± 1.6) was similar to that of mantle cells (MFI = 5.4 ± 2.6), but germinal center cells, depicted by their intense expression, showed a near absence of bcl-2 (MFI = 1.5 ±.6). In F, the neoplastic B cells showed bcl-2 content (MFI = 22.2 ± 14.1) that was significantly higher than that of the T-cell population in the same tumor (MFI = 7.1 ± 2.3; P <.2), as well as all other cell populations of FH, particularly the FH germinal center cells (P <.1). The population of cells (mostly T American Society of Clinical Pathologists Am J Clin Pathol 2;114:
3 Cornfield et al / ANAYSIS OF BC-2 IN YMPHOMA AND HYPERPASIA A B T M 1 3 T bcl bcl GC Figure 1 Correlated analysis of surface and intracellular bcl-2 in a representative case of follicular hyperplasia (A) and follicular lymphoma (B). A, identifies 3 distinct populations with increasing levels of expression, corresponding mostly to T cells, mantle B cells, and germinal center B cells, respectively. Germinal center (GC) cells show virtually no expression of bcl-2, equivalent to the isotype-matched control (not shown). Higher bcl-2 expression is seen in T cells (T) and in mantle B cells (M). The follicular lymphoma case (B) displays 2 major populations: T lymphocytes (T) and + lymphoma cells () (recognized as such by their expression of a single immunoglobulin light chain, not shown). The malignant B cells express a high level of bcl-2. 6 bcl-2 Expression (MFI) T Cells Mantle Germinal Center T Cells Follicular Hyperplasia Follicular ymphoma Figure 2 Mean fluorescence intensity (MFI) for bcl-2 in the different lymphoid populations of follicular hyperplasias and follicular lymphomas. Significant differences in MFI were observed between the follicular lymphoma B cells and the T cells within the same tumors (P <.2) and the germinal center cells in follicular hyperplasias (P <.1). Also, the T cells of follicular lymphomas demonstrated a significantly higher bcl-2 expression than the T cells in follicular hyperplasias (P =.2). In cases of partial lymphoma involvement, the MFI of the bcl-2 expression corresponds only to the neoplastic component. Error bars represent SD. 26 Am J Clin Pathol 2;114: American Society of Clinical Pathologists
4 Hematopathology / ORIGINA ARTICE cells) in cases of F demonstrated a significantly higher bcl- 2 expression (MFI = 7.1 ± 2.3) than the equivalent population in cases of FH (MFI = 4.7 ± 1.6; P =.2). In 5 cases, there was only partial involvement of the node by F, and neoplastic B cells were admixed with numerous normal B cells. These 2 B-cell populations were different in expression, and their nature was determined by their corresponding surface immunoglobulin light chain distribution. Thus, normal B cells showed a polytypic distribution (a mixture of kappa- and lambda-bearing cells), whereas neoplastic B cells exhibited a single or no light chain expression Figure 3A and Figure 3B. The intensely staining + cells, corresponding to the lymphoma elements, showed higher bcl-2 expression than the less intense + normal B cells Figure 3C. The bcl-2 MFI of the neoplastic cells in these F cases with partial lymphoma involvement (23.66 ± 16.35) was not different from that of the more advanced cases (21.53 ± 13.85). Molecular analysis revealed the presence of a bcl-2 gene translocation in 1 (59%) of 17 cases of F in this series. The intensity of bcl-2 expression in lymphoma cells of cases with a molecular translocation (25.5 ± 16.32) did not differ significantly from that of cases not demonstrating such a translocation (17.37 ± 9.35; P =.21). A B lambda kappa Polytypic Polytypic Discussion By using a relatively simple flow cytometric technique that used simultaneous staining of cell surface and intracellular bcl-2, we demonstrated a pattern of bcl-2 expression in F that is distinct from that of FH. was chosen because it is a universal marker of peripheral B cells and is differentially expressed in mantle and germinal center B cells. 7 Other markers preferentially expressed in germinal center cells could be used but are less discriminatory. 8 In F, the + malignant cells showed strong bcl-2 expression. This expression was higher than that of any cell subpopulation of FH and strikingly different from the intensely + germinal center cells, which typically do not express bcl-2. The differences in bcl-2 expression between normal and F cells was clearly illustrated also in the few cases of partial involvement by lymphoma, in which the level of expression of bcl-2 in the malignant cells was as high as that of neoplastic cells in nodes fully involved by F. The distinction between FH and F sometimes may be extremely difficult. Molecular techniques and immunohistology can aid in establishing a firm diagnosis, but these techniques are not sufficiently specific, may be subject to a variety of methodologic artifacts, and fail to recognize some cases of F. Immunophenotyping by flow cytometry can provide additional and often diagnostic information and is C bcl Polytypic Figure 3 ymph node partially involved by follicular lymphoma (F). The node contains normal B cells as well as F cells. In A and B, simultaneous surface and immunoglobulin light chain staining identifies normal (polytypic) B cells (vertical boxes) consisting of a mixture of kappa- and lambda-bearing cells. ymphoma cells () express (faintly) kappa but no lambda immunoglobulin. C, A high level of bcl-2 is shown in the more intensely -expressing lymphoma cells. American Society of Clinical Pathologists Am J Clin Pathol 2;114:
5 Cornfield et al / ANAYSIS OF BC-2 IN YMPHOMA AND HYPERPASIA particularly useful when limited biopsy material precludes adequate morphologic assessment. It is also of value when fine-needle aspiration of lymphoid material is thought to be preferable to surgical biopsy for reasons of safety and convenience, as in elderly patients with retroperitoneal lymphadenopathy. The flow cytometry distinction of F from FH is based largely on the identification of a B-cell population with immunoglobulin light chain restriction and expression of CD1. 8 Our results show that the analysis of bcl-2 expression by flow cytometry adds an additional piece of confirmatory data that, in difficult or inconclusive cases, can help establish the diagnosis of F. This is useful when tumor cells fail to express immunoglobulin light chain, as observed in 2 of our cases, which showed molecular, morphologic, and immunohistochemical evidence of F but failed to express monoclonal light chain immunoglobulin by flow cytometry. Both cases demonstrated bcl-2 expression in the intense + cell population. It should be noted that approximately 1% to 15% of Fs do not overexpress bcl-2. 2,5 In these cases, evaluation of bcl-2 by flow cytometry would not be expected to provide useful information, although other potential results generated by flow cytometry, such as monotypic light chain expression or strong CD1 expression by a B-cell population, might suggest the diagnosis. The finding that T lymphocytes express higher levels of bcl-2 in F than in FH was unexpected. The factors that govern bcl-2 expression in reactive T lymphocytes are largely unknown. More than 8% of normal T cells express bcl-2 protein, and this expression can be maintained for at least several weeks under continued mitogenic stimulation. 11 It has been shown that viability factors such as interleukin-2 can induce endogenous bcl-2 messenger RNA expression in interleukin-2 dependent cells like the cytotoxic T-cell line CT2. 12 It might be postulated that the presence of interleukins or other factors in the local environment of F or even direct contact between the neoplastic cells of F and tumor-infiltrating T lymphocytes results in stimulation of T- cell bcl-2 messenger RNA and protein expression. At present, the mechanisms responsible for the enhanced bcl-2 protein expression that we observed in T lymphocytes remain entirely conjectural. B-cell lymphomas other than F may express bcl-2, as demonstrated by immunohistochemical methods in paraffinembedded tissue. 3,5 Thus, the simple detection of this protein would not help in identifying specific lymphoma types. Flow cytometry has the advantage of being highly quantitative and is an excellent means of measuring products at the cellular level, but the cytometric quantitation of bcl-2 protein in lymphomas has received virtually no attention in the medical literature. In this regard, it would be of interest to determine whether different types of bcl-2-expressing lymphomas exhibit measurable differences in bcl-2 content that may aid in their classification. It has been shown that bcl-2 expression is an adverse prognostic factor with regard to overall and disease-free survival in diffuse large cell lymphomas. 13,14 Its prognostic value in F is much less clear, with some observers claiming a poor overall prognosis 15 or freedom from progression after chemotherapy 16 in bcl-2 positive cases, and others 17 claiming no such relationship. Whether quantitative measurement of bcl-2 expression, rather than assessing only positivity or negativity, would add any useful prognostic information remains to be determined. From the Department of Pathology and aboratory Medicine, and Shands Hospital, University of Florida College of Medicine, Gainesville, F. Address reprint requests to Dr Braylan: Hematopathology Section, Dept of Pathology and aboratory Medicine, Box 1275, University of Florida College of Medicine, Gainesville, F References 1. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 199;348: Utz G, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol. 1993;24: Wang T, asota J, Hanau CA, et al. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. APMIS. 1995;13: Gaulard P, d Agay MF, Peuchmaur M, et al. Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol. 1992;14: Zutter M, Hockenbery D, Silverman GA, et al. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood. 1991;78: Ngan BY, Chen-evy Z, Weiss M, et al. Expression in non- Hodgkin s lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988;318: Gadol N, Peacock MA, Ault KA. Antigenic phenotype and functional characterization of human tonsil B cells. Blood. 1988;71: Almasri NM, Iturraspe JA, Braylan RC. CD1 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Arch Pathol ab Med. 1998;122: iu J, Johnson RM, Traweek ST. Rearrangement of the BC-2 gene in follicular lymphoma: detection by PCR in both fresh and fixed tissue samples. Diagn Mol Pathol. 1993;2: Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16: Am J Clin Pathol 2;114: American Society of Clinical Pathologists
6 Hematopathology / ORIGINA ARTICE 11. Aiello A, Delia D, Borrello MG, et al. Flow cytometric detection of the mitochondrial BC-2 protein in normal and neoplastic human lymphoid cells. Cytometry. 1992;13: Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2 mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci U S A. 1993;9: Hermine O, Haioun C, epage E, et al. Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin s lymphoma. Groupe d Etude des ymphomes de l Adulte (GEA). Blood. 1996;87: Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-hodgkin s lymphoma. Blood. 1997;9: Martinka M, Comeau T, Foyle A, et al. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clin Invest Med. 1997;2: Wendum D, Sebban C, Gaulard P, et al. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the NH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d Etude des ymphomes de l Adulte. J Clin Oncol. 1997;15: Pezzella F, Jones M, Ralfkiaer E, et al. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer. 1992;65: American Society of Clinical Pathologists Am J Clin Pathol 2;114:
Case 3. Ann T. Moriarty,MD
Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.
More informationMolecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU
Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology
More informationLack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral B-Cell Lymphoma
Hematopathology / SURFACE IMMUNOGLOBULIN LIGHT CHAIN NEGATIVE PERIPHERAL B-CELL LYMPHOMA Lack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationFOLLICULARITY in LYMPHOMA
FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular
More informationMimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical
More informationCase Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent
Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,
More informationMimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this
More informationComposite mantle cell and follicular lymphoma. A case report
Human Pathology (2009) 40, 259 263 www.elsevier.com/locate/humpath Case study Composite mantle cell and follicular lymphoma. A case report Raquel B. Ilgenfritz MD a,, Agnès Le Tourneau MD a, Michel Arborio
More informationFlow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report
Jichi Medical University Journal Flow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report Satoko Oka,, Kazuo Muroi,, Kazuya
More informationImmunopathology of Lymphoma
Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.
More informationOriginal Article Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasia
Int J Clin Exp Pathol 2012;5(2):110-118 www.ijcep.com /ISSN: 1936-2625/IJCEP1112008 Original Article Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid
More informationGENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute
GENETIC MARKERS IN LYMPHOMA a practical overview P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute B and T cell monoclonalities Rearrangement of immunoglobin and TCR genes may help
More informationImmunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation
Immunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation Toshinobu Kubota, Yasushi Yatabe, Shinobu Awaya, Junpei Asai and Naoyoshi Mori Department of Ophthalmology and Pathology,
More informationImmunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
Hematopathology / IMMUNOPHENOTYPE OF LPL/WM Immunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Sergej Konoplev, MD, PhD, L. Jeffrey Medeiros, MD, Carlos E. Bueso-Ramos,
More informationQUANT BCL2/IGH Cat Real Time Quantitative PCR of t(14;18) (Bcl2/IgH) for diagnosis and monitoring of follicular Cell lymphoma
QUANT BCL2/IGH Cat.1.006 Real Time Quantitative PCR of t(14;18) (Bcl2/IgH) for diagnosis and monitoring of follicular Cell lymphoma Follicular)Cell)Lymphoma)(FCL))is)the)most)common)indolent)non7Hodgkin
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationClassification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
More informationRNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using
Supplementary Information Materials and Methods RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using Trizol reagent (Invitrogen,Carlsbad, CA) according to the manufacturer's instructions.
More informationTest Utilization: Chronic Lymphocytic Leukemia
Test Utilization: Chronic Lymphocytic Leukemia Initial Evaluation Diagnostic Criteria Selection of Tests for Prognosis Response to Therapy Challenges Assessment for persistent disease Paul J. Kurtin, M.D.
More informationThe development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory
The development of clonality testing for lymphomas in the Bristol Genetics Laboratory Dr Paula Waits Bristol Genetics Laboratory Introduction The majority of lymphoid malignancies belong to the B cell
More informationMolecular Probes Introducing 14 new probes
Molecular Probes Introducing 14 new probes Gene and Chromosome Probes Dual Colour ISH INFORM HER2 Dual ISH DNA Probe Cocktail Assay Product Part Number INFORM HER2 Dual ISH DNA Probe Cocktail 800-4422
More informationLymphoma and Pseudolymphoma
Lymphoma and Pseudolymphoma Laura B. Pincus, MD Co-Director, Cutaneous Lymphoma Clinic Associate Professor Dermatology and Pathology University of California, San Francisco I HAVE NO RELEVANT RELATIONSHIPS
More informationMantle Cell Lymphoma
HEMATOPATHOLOGY Original Article Mantle Cell Lymphoma Morphologic Findings in Bone Marrow Involvement JAY WASMAN, MD, 1 NANCY S. ROSENTHAL, MD,' AND DIANE C. FARHI, MD 2 Although mantle cell lymphoma (MCL),
More informationCD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting
Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja
More informationSuccessful flow cytometric immunophenotyping of body fluid specimens
Successful flow cytometric immunophenotyping of body fluid specimens Fiona E. Craig, MD Division of Hematopathology Mayo Clinic Arizona 2017 MFMER slide-1 Financial disclosure No conflicts 2017 MFMER slide-2
More informationCritical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry
Hematopathology / FLOW CYTOMETRIC IMMUNOPHENOTYPING IN B-CELL NON-HODGKIN LYMPHOMA Critical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry
More informationContents. vii. Preface... Acknowledgments... v xiii
Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationMalignant lymphomas are neoplasms that arise from B
Overview of the Role of Molecular Methods in the Diagnosis of Malignant Lymphomas L. Jeffrey Medeiros, MD; Jeanne Carr, PhD Objective. To review the role of molecular genetics in the diagnosis of malignant
More informationThe Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.
The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More informationHyperplasia of Mantle/Marginal Zone B Cells With Clear Cytoplasm in Peripheral Lymph Nodes A Clinicopathologic Study of 35 Cases
Hematopathology / HYPERPLASIA OF MANTLE/MARGINAL ZONE B CELLS WITH CLEAR CYTOPLASM Hyperplasia of Mantle/Marginal Zone B Cells With Clear Cytoplasm in Peripheral Lymph Nodes A Clinicopathologic Study of
More informationPeripheral blood Pleural effusion in a cat
Tools for the Diagnosis of Lymphoproliferative Diseases When is it difficult to diagnose lymphoproliferative disease? Persistent lymphocytosis consisting of small Lymph node aspirates containing an excess
More information88-year-old Female with Lymphadenopathy. Faizi Ali, MD
88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and
More informationCase Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case
Int J Clin Exp Pathol 2014;7(10):7100-7104 www.ijcep.com /ISSN:1936-2625/IJCEP0001717 Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case Jenny
More informationAnnexin V-APC/7-AAD Apoptosis Kit
Annexin V-APC/7-AAD Apoptosis Kit Catalog Number KA3808 100 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4
More informationPrepared by: Dr.Mansour Al-Yazji
C L L CLL Prepared by: Abd El-Hakeem Abd El-Rahman Abu Naser Ahmed Khamis Abu Warda Ahmed Mohammed Abu Ghaben Bassel Ziad Abu Warda Nedal Mostafa El-Nahhal Dr.Mansour Al-Yazji LEUKEMIA Leukemia is a form
More information11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS
Bharat N. Nathwani, M.D. City of Hope Medical Center Professor, Director of Pathology Consultation Services, 1500 East Duarte Road, Duarte, California, 91010 DISCLOSURES -------------------------------------------------------
More informationA Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D.
A Practical Guide To Diagnose B-Cell Lymphomas on FNAs Nancy P. Caraway, M.D. Major Factors Impacting Dx Lymphomas on Small Bxs Classification systems Immunophenotyping by multiprobe flow cytometry and
More informationPathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e
Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long
More information7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit
7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit Catalog Number KA1293 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/39089 holds various files of this Leiden University dissertation. Author: Cetinozman, F. Title: PD-1 Expression in primary cutaneous lymphoma Issue Date:
More informationMuse Assays for Cell Analysis
Muse Assays for Cell Analysis Multiple Assay Outputs for Cell Analysis Cell Health Cell Signalling Immunology Muse Count & Viability Kit Muse Cell Cycle Kit Muse Annexin V & Dead Cell Kit Muse Caspase
More informationSignificant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow
Hematopathology / CD5 Expression on Normal B Cells Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow Franklin S. Fuda, DO, Nitin J. Karandikar, MD, PhD, and
More informationDiagnosis of lymphoid neoplasms has been
Iranian Journal of Pathology (2007)2 (1), 1-61 Review Article Mehdi Nassiri Dep. of Pathology, University of Miami Miller School of Medicine, Miami, USA Abstract Correct diagnosis and classification of
More informationVDx: Unlocking Complex Diagnostics
VDx: Unlocking Complex Diagnostics VDx now offers PARR testing in-house on formalin-fixed tissue Complicated Case? Is this cat s chronic lymphocytic enteritis really chronic IBD or is this early small
More informationLymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients
Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,
More informationFollicular Lymphoma: the WHO
Follicular Lymphoma: the WHO and the WHERE? Yuri Fedoriw, MD Associate Professor of Pathology and Laboratory Medicine Director of Hematopathology University of North Carolina Chapel Hill, NC Disclosure
More informationDiagnostic Usefulness of CD23 and FMC-7 Antigen Expression Patterns in B-Cell Lymphoma Classification
Hematopathology / AND ANTIGEN EXPRESSION IN B-CELL LYMPHOMA CLASSIFICATION Diagnostic Usefulness of and Antigen Expression Patterns in B-Cell Lymphoma Classification Diana P. Garcia, MD, 1* Michele T.
More informationMethods used to diagnose lymphomas
Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry
More informationNon-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)
Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma
More informationThe Annexin V Apoptosis Assay
The Annexin V Apoptosis Assay Development of the Annexin V Apoptosis Assay: 1990 Andree at al. found that a protein, Vascular Anticoagulant α, bound to phospholipid bilayers in a calcium dependent manner.
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationLymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York
Lymphocytoma Cutis Cynthia M. Magro MD Professor of Pathology Director of Dermatopathology Weill Medical College of Cornell University New York, New York Lymphocytoma Cutis Falls under other designations
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationImmunohistochemical Evaluation of Necrotic Malignant Melanomas
Anatomic Pathology / EVALUATION OF NECROTIC MALIGNANT MELANOMAS Immunohistochemical Evaluation of Necrotic Malignant Melanomas Daisuke Nonaka, MD, Jordan Laser, MD, Rachel Tucker, HTL(ASCP), and Jonathan
More informationPearls and pitfalls in interpretation of lymphoid lesions in needle biopsies
Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Megan S. Lim MD PhD University of Pennsylvania October 8, 2018 Objectives To understand how the trend toward less invasive lymph
More informationFlow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies
Hematopathology / Light Chain Expression in B-NHLs Flow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies Pedro Horna, MD, Horatiu
More informationSolomon Graf, MD February 22, 2013
Solomon Graf, MD February 22, 2013 Case Review of FL pathology, prognosis Grading of FL Grade 3 disease High proliferative index in grade 1/2 disease Pediatric FL Future of FL classification 57 yo man
More informationDetailed step-by-step operating procedures for NK cell and CTL degranulation assays
Supplemental methods Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Materials PBMC isolated from patients, relatives and healthy donors as control K562 cells (ATCC,
More informationECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas
ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas Philippe Gaulard, Dept of Pathology, INSERM U955, Hôpital Henri Mondor, 94010 -
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationIn recent years, molecular characterization of hematologic
J Vet Intern Med 2006;20:329 334 Utility of Polymerase Chain Reaction for Analysis of Antigen Receptor Rearrangement in Staging and Predicting Prognosis in Dogs with Lymphoma Susan E. Lana, Tracey L. Jackson,
More informationPBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human
Anti-CD19-CAR transduced T-cell preparation PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human AB serum (Gemini) and 300 international units/ml IL-2 (Novartis). T cell proliferation
More informationBACKGROUND AND OBJECTIVE:
Fine needle aspiration cytology in the evaluation of lymphoid lesions: a retrospective study of the utility of flow cytometry in conjunction with morphology Emad M. Said Raddaoui, a Lubna Sayage-Rabie,
More informationLeukemic Phase of Mantle Cell Lymphoma, Blastoid Variant
Hematopathology / LEUKEMIC BLASTOID MANTLE CELL LYMPHOMA Leukemic Phase of Mantle Cell Lymphoma, Blastoid Variant Timothy P. Singleton, MD, Margaret M. Anderson, MD, Charles W. Ross, MD, and Bertram Schnitzer,
More informationCME/SAM. Abstract. Hematopathology / CD103 and CD123 in B-Cell Neoplasia
Hematopathology / CD103 and CD123 in B-Cell Neoplasia Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia Usefulness of CD123 and CD103 in the Diagnosis of Mature B-Cell Lymphoproliferative
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood
More informationRapid antigen-specific T cell enrichment (Rapid ARTE)
Direct ex vivo characterization of human antigen-specific CD154+CD4+ T cell Rapid antigen-specific T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central role
More information5/16/2018 HEMATOPATHOLOGY FOR CYTOPATHOLOGISTS HEMATOPATHOLOGY FOR C CYTOPATHOLOGISTS I HAVE NOTHING TO C DISCLOSE
HEMATOPATHOLOGY FOR C CYTOPATHOLOGISTS Kathryn Lindsey, MD McKee Cytology Symposium HEMATOPATHOLOGY FOR C CYTOPATHOLOGISTS Kathryn Lindsey, MD McKee Cytology Symposium I HAVE NOTHING TO C DISCLOSE Kathryn
More informationCase Report Synchronous Pulmonary Squamous Cell Carcinoma and Mantle Cell Lymphoma of the Lymph Node
Case Reports in Genetics Volume 2011, Article ID 945181, 5 pages doi:10.1155/2011/945181 Case Report Synchronous Pulmonary Squamous Cell Carcinoma and Mantle Cell Lymphoma of the Lymph Node Yu Sun, 1 Yun-Fei
More informationHEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor
HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain
More informationof Lymph Node Biopsies
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 1994, p. 299-303 Vol. 1, No. 3 1071-412X/94/$04.00+0 Copyright C) 1994, American Society for Microbiology A Comparative Study of Frozen-Section Immunoperoxidase
More informationBurkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8
Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology
More informationCCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma
AJCP /CASE REPORT CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma Yuan Miao, MD, 1,2 Pei Lin, MD, 1 Wei Wang, MD, 1 L. Jeffrey Medeiros, MD,
More informationThe spectrum of flow cytometry of the bone marrow
The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests
More informationUniversity of Groningen. The microenvironment of Hodgkin lymphoma Sattarzadeh, Ahmad
University of Groningen The microenvironment of Hodgkin lymphoma Sattarzadeh, Ahmad IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationDefined lymphoma entities in the current WHO classification
Defined lymphoma entities in the current WHO classification Luca Mazzucchelli Istituto cantonale di patologia, Locarno Bellinzona, January 29-31, 2016 Evolution of lymphoma classification Rappaport Lukes
More informationABERRANT EXPRESSION OF CD19 AND CD43
ABERRANT EXPRESSION OF CD19 AND CD43 IN A PATIENT WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA AND A HISTORY OF MANTLE CELL LYMPHOMA Yen-Chuan Hsieh, 1 Chien-Liang Lin, 2 Chao-Jung Tsao, 2 Pin-Pen Hsieh,
More informationSmad1 Expression in Follicular Lymphoma
Journal of Pathology and Translational Medicine 2015; 49: 243-248 ORIGINAL ARTICLE Smad1 Expression in Follicular Lymphoma Jai Hyang Go Department of Pathology, Dankook University College of Medicine,
More informationMATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All
MATERIALS AND METHODS Antibodies (Abs), flow cytometry analysis and cell lines Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All other antibodies used
More informationThe Lymphomas. An overview..
The Lymphomas An overview.. Peter Anglin MD, FRCPC, MBA Stronach Regional Cancer Centre Newmarket, ON The lymphomas are an important part of the history of medicine 1666 Magpighi publishes first recorded
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationSession 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi
Session 5 Pre-malignant clonal hematopoietic proliferations Chairs: Frank Kuo and Valentina Nardi Pre-malignant clonal hematopoietic proliferations Clonal LYMPHOID proliferations: - Monoclonal gammopathy
More informationPrimary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report
Primary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report Pages with reference to book, From 148 To 149 Suhail Muzaffar,Irshad Nabi Soomro,Naila Kayani,Shahid Siddiqui ( Departments of Pathology, The Aga
More informationRoutine staging in non-hodgkin s lymphomas
Malignant Lymphomas Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas original paper haematologica 2001; 86:934-940 http://www.haematologica.it/2001_09/0934.htm
More informationIndependent Diagnostic Accuracy of Flow Cytometry Obtained From Fine-Needle Aspirates A 10-Year Experience With 451 Cases
Hematopathology / Diagnostic Accuracy of Flow Cytometry Independent Diagnostic Accuracy of Flow Cytometry Obtained From Fine-Needle Aspirates A 10-Year Experience With 451 Cases Erica C. Savage, MD, 1
More informationEpstein-Barr Virus Associated High-Grade B-Cell Lymphoma of Mucosal-Associated Lymphoid Tissue in a 9-Year-Old Boy
Epstein-Barr Virus Associated High-Grade B-Cell Lymphoma of Mucosal-Associated Lymphoid Tissue in a 9-Year-Old Boy We report an unusual case of Epstein-Barr virus (EBV)- associated mucosal-associated lymphoid
More informationCase Report Follicular lymphoma mimicking marginal zone lymphoma in lymph node: a case report
Int J Clin Exp Pathol 2014;7(10):7076-7081 www.ijcep.com /ISSN:1936-2625/IJCEP0001940 Case Report Follicular lymphoma mimicking marginal zone lymphoma in lymph node: a case report Ikuo Matsuda 1, Yoshifumi
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationLarge cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s
Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of
More informationConjunctival CD5+ MALT lymphoma and review of literatures
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Conjunctival CD5+ MALT lymphoma and review of literatures M Fard Citation M Fard. Conjunctival CD5+ MALT lymphoma and review of literatures.
More informationDo Your Flow Cytometric LDTs. Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine
Do Your Flow Cytometric LDTs Conform to the ICSH ICCS Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine How should LDTs be validated? Accuracy Specificity Sensitivity
More informationCME/SAM. Olga Pozdnyakova, MD, PhD, 1 Svetlana Kondtratiev, MD, 1,2 Betty Li, MS, 1 Karry Charest, 1 and David M. Dorfman, MD, PhD 1.
Hematopathology / New Mastocytosis Flow Cytometry Approach High-Sensitivity Flow Cytometric Analysis for the Evaluation of Systemic Mastocytosis Including the Identification of a New Flow Cytometric Criterion
More informationClonal Heterogeneity Assessed by Flow Cytometry in B-Cell Lymphomas Arising From Germinal Centers
Hematopathology / CLONAL HETEROGENEITY IN B-CELL LYMPHOMAS Clonal Heterogeneity Assessed by Flow Cytometry in B-Cell Lymphomas Arising From Germinal Centers Mar Bellido, MD, 1 Enriqueta Rubiol, 1 Josep
More informationDirect ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE)
Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central
More informationV. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach
V. Acute leukemia Evaluating a sample for an acute leukemia Acute leukemia is a neoplasm of immature myeloid or lymphoid cells characterized by a block in maturation, usually at the stage of an early progenitor
More information